IL6 and neoplasm: It has been reported that M2-type TAMs contribute to the vascular proliferation of GBM cells by releasing insulin-like growth factor binding protein 1 (IGFBP1) and IL-6 to contribute to the expansion of tumor blood vessels in TME and the enhancement of blood supply to tumor tissues (74).